China Risun Group SEHK 1907 Thin 0.1% Margin Recovery Tests Bullish Earnings Narratives

China Risun Group (SEHK:1907) has reported FY 2025 first half revenue of C¥20.5b and basic EPS of C¥0.0066, with the latest twelve month figures showing revenue of C¥39.3b and basic EPS of C¥0.013. The company has seen revenue move from C¥25.2b in the first half of 2024 to C¥22.3b in the second half of 2024 and then to C¥20.5b in the first half of 2025. Over the same periods, basic EPS shifted from C¥0.025383 to a loss of C¥0.021219 and then to C¥0.0066, setting up an earnings story that now hinges on how thin margins at around 0.1% are perceived relative to the recent rebound in earnings. See our full analysis for China Risun Group.With the headline numbers on the table, the next step is to see how these results compare with the prevailing narratives around China Risun Group's growth potential, risk profile, and earnings quality. Curious how numbers become stories that shape markets? Explore Community Narratives Margins Thin, But 0.1% Profit Beats Last Year Net profit margin for the latest twelve months sits at 0.1%, compared with 0.04% over the prior year, on C¥39.3b of revenue and C¥58.0m of net income excluding extra items. Bulls point to this margin improvement as evidence that the business can still grind out profits. Yet the tiny spread between C¥39.3b of sales and only C¥58.0m of net income means even small cost or pricing shifts could quickly pressure that optimistic view. Supporters of the bullish take may highlight that earnings grew 188.1% over the last year, but critics can counter that this growth comes off a very low base, with margins still close to break even. The move from a 0.04% to 0.1% margin shows some progress, while the half year pattern of C¥111.9m profit, then a C¥91.7m loss, then C¥28.6m profit underscores how sensitive these thin margins are to swings in operating conditions. Earnings Swing From C¥91.7m Loss To C¥28.6m Profit Net income excluding extra items moved from a loss of C¥91.7m in the second half of 2024 to a profit of C¥28.6m in the first half of 2025, while basic EPS shifted from a loss of C¥0.021219 to a gain of C¥0.0066 over the same stretch. What challenges a bearish stance that treats recent results as structurally weak is that, on a trailing twelve month view, earnings rose 188.1% even though the last three half year periods ranged from a C¥91.7m loss to C¥111.9m profit, which suggests volatility in individual halves sits alongside clear improvement in the aggregated year. Bears who focus on the 51.5% annual decline in earnings over five years can point to that longer run pattern, yet have to reconcile it with the latest twelve month outcome of C¥58.0m in profit versus only C¥20.1m in the comparable prior period. The sequence of basic EPS readings, from C¥0.025383 to a loss of C¥0.021219 and back to a positive C¥0.0066, shows that earnings are not on a straight line, which lends some support to cautious views even as the last twelve months in aggregate look better than the multi year trend. Low 0.3x P/S And DCF Fair Value Of HK$18.71 The shares trade on a P/S ratio of 0.3x, versus 0.6x for the Hong Kong chemicals industry and 0.5x for peers, while the DCF fair value in the dataset is HK$18.71 compared with the current share price of HK$3.44. Supporters of the bullish narrative see the combination of low P/S and a DCF fair value that is more than 5x the current HK$3.44 price as a sign of potential mispricing. Yet the same dataset also flags that interest payments are not well covered by earnings, so the apparent valuation gap sits alongside a clear financing risk. The valuation gap is underpinned by forecasts in the dataset that call for 55.3% annual earnings growth and about 10.4% annual revenue growth over the next three years, which helps explain why a DCF model could arrive at HK$18.71. At the same time, the weak interest coverage means any shortfall in those growth expectations could weigh directly on equity holders, which is why investors focused on downside risk may treat the discount to DCF and peer P/S multiples as only one part of the overall picture. Curious how other investors are connecting these thin margins, big earnings swings, and the wide gap to DCF fair value with their own narratives around China Risun Group? Curious how numbers become stories that shape markets? Explore Community Narratives Next Steps Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on China Risun Group's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move. Mixed messages from the numbers so far? Use the data, recent earnings swings, and valuation context to stress test your own thesis with 4 key rewards and 1 important warning sign See What Else Is Out There China Risun Group's extremely thin margins, earnings volatility between profits and losses, and weak interest coverage paint a picture of a business with financial fragility and elevated risk. If that level of earnings swing and financing strain feels uncomfortable, shift your focus to companies screened for stronger financial footing and cash resilience with solid balance sheet and fundamentals stocks screener (382 results) This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.